It is well known that skeletal scintigraphy is an imaging modality with high sensitivity but low specificity. Sites of IRU provide good evidence of increased bone turnover but not its specific cause. Results of lameness workups, blocks, and other imaging techniques are required to determine specific causes. Overinterpretation of causes of IRU is tempting, especially in assigning diagnoses to EIBR--adaptive or non-adaptive. Nevertheless, a quarter of a century's experience with equine skeletal scintigraphy has shown that certain patterns and locations can be fairly predictive of certain pathologic findings. It behooves the equine scintigrapher to know those patterns and how they are affected by the patient's age, breed, and occupation so that he or she can indicate how to best focus other diagnostic procedures toward a definitive diagnosis. Those who are conducting research involving equine skeletal scintigraphy are challenged to help sharpen that focus, especially in evaluating the significance of relatively mild IRUs. Equine clinicians who use scintigraphy in their lameness workups are especially challenged. Working in concert with nuclear medicine imagers, they are in the best position to garner, collate, and analyze the information that is needed to correlate IRUs and the clinical picture. As difficult as they are to design and conduct, such studies are most productive if done prospectively and are most rewarding for those who carry them through.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0749-0739(17)30076-7 | DOI Listing |
Alzheimers Dement
December 2024
Medical College, the Catholic University of Korea, Seoul, Korea, Republic of (South).
Background: Although previous studies have demonstrated cognitive impairment in elderly individuals with sarcopenia and its neuronal substrates, there is no comprehensive model integrating multiple brain pathologies to predict cognitive impairment associated with sarcopenia. The aim of this study was to explore a comprehensive prediction model for cognitive impairment in sarcopenia using multimodal neuroimaging methods in non-demented older adults.
Method: This cross-sectional study used data from the Catholic Aging Brain Imaging Database study, a population-based cohort study with magnetic resonance imaging (MRI) scans, positron emission tomography (PET) scans, and clinical data.
Clin Nucl Med
February 2025
From the Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Prostate cancer frequently metastasizes to bones; however, the detection of metastases can be challenging in rare locations. We present the case of a 76-year-old man with metastatic castration-resistant prostate cancer with lymph nodal and skeletal metastases who underwent 177Lu-prostate-specific membrane antigen (PSMA) therapy. Initial 18F-PSMA PET/CT scan acquired until the midthigh failed to identify metastases in the foot, but posttherapy 177Lu-PSMA scan revealed the presence of metastases in the navicular and cuboid bones of the right foot, which is a very rare finding.
View Article and Find Full Text PDFClin Nucl Med
February 2025
From the Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai West, New York, NY.
Extranodal natural killer/T-cell lymphoma (ENKTCL) is an aggressive EBV-associated non-Hodgkin lymphoma, most commonly arising from within the mucosa of the upper aerodigestive tract, typically with nasal presentation. Here, we present an interesting case of a 36-year-old man with ENKTCL with an atypical pattern of disease progression despite 3 cycles of SMILE chemotherapy. Restaging 18F-FDG PET/CT demonstrated widespread uptake within the skeletal musculature in a distribution concerning for a paraneoplastic polymyositis.
View Article and Find Full Text PDFBMC Endocr Disord
January 2025
Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, Republic of Korea.
Background: Despite TSH suppressive therapy improve the prognosis for the patient with differentiated thyroid cancer (DTC), there is an increasing concern regarding the potentially harmful effects of lifelong TSH suppression. Therefore, we aimed to examine the changes in body composition under TSH suppression in postmenopausal women with DTC.
Methods: The body composition was assessed by the volumes as following; fat tissues of the epicardium and abdominal visceral and subcutaneous areas; bilateral psoas muscle or thigh muscle.
Mol Neurodegener
January 2025
Faculty of Life and Health Sciences, Shenzhen University of Advanced Technology (SUAT), Shenzhen, China.
Synucleinopathies, such as Parkinson's disease, dementia with Lewy bodies, and multiple system atrophy, are characterized by the aggregation of α-synuclein. Variations in brain distribution allow for differentiation among these diseases and facilitate precise clinical diagnosis. However, distinguishing between synucleinopathies and Parkinsonism with tauopathies poses a challenge, significantly impacting clinical drug development.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!